«

»

Delix Therapeutics Pursues A Psychedelic-Inspired Medicine Without The Trip

The Boston-based neuroscience startup raised $70 million to turn its patented molecules based on classic psychedelic drugs into medicine.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive